Evidence map›Paper›PMID 33351782›Full record

ArticleJCI insight2021

Tregs facilitate obesity and insulin resistance via a Blimp-1/IL-10 axis.

Lisa Y Beppu, Raja Gopal Reddy Mooli, Xiaoyao Qu, Giovanni J Marrero, Christopher A Finley, Allen N Fooks, Zackary P Mullen, Adolfo B Frias, Ian Sipula, Bingxian Xie and 6 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. New Mediators in the Crosstalk between Different Adipose Tissues.International journal of molecular sciences · 2024
    Pooled it
  2. Review
  3. Regulatory T cells in cancer and inflammation.Signal transduction and targeted therapy · 2026
    Review
  4. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Lisa Y BeppuDepartment of Immunology.
Raja Gopal Reddy MooliDivison of Endocrinology, Department of Medicine, and the Center for Metabolism and Mitochondrial Medicine.
Xiaoyao QuDepartment of Immunology.
Giovanni J MarreroDepartment of Immunology.
Christopher A FinleyDepartment of Immunology.
Allen N FooksDepartment of Immunology.
Zackary P MullenDepartment of Immunology.
Adolfo B FriasDepartment of Immunology.
Ian SipulaDivison of Endocrinology, Department of Medicine, and the Center for Metabolism and Mitochondrial Medicine.
Bingxian XieDivison of Endocrinology, Department of Medicine, and the Center for Metabolism and Mitochondrial Medicine.
Katherine E HelfrichCenter for Biologic Imaging; and.
Simon C WatkinsCenter for Biologic Imaging; and.
Amanda C PoholekDepartment of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sadeesh K RamakrishnanDivison of Endocrinology, Department of Medicine, and the Center for Metabolism and Mitochondrial Medicine.
Michael J JurczakDivison of Endocrinology, Department of Medicine, and the Center for Metabolism and Mitochondrial Medicine.
Louise M D'CruzDepartment of Immunology.
Biolog (United States) · USUniversity of Pittsburgh · US

Funding

Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6M
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLDR01DK119627 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JURCZAK, MICHAEL J., LIU, YUAN · 2019 to 2023
$2.0M
Obesity-associated Mitophagy ResistanceR01DK114012 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JURCZAK, MICHAEL J. · 2018 to 2022
$1.8M
NIAID NIH HHS T32 AI089443NIDDK NIH HHS R01 DK114012NIDDK NIH HHS R01 DK119627
6 · The paper itself

Abstract

Interleukin-10 (IL-10) is a critical cytokine used by immune cells to suppress inflammation. Paradoxically, immune cell-derived IL-10 can drive insulin resistance in obesity by suppressing adipocyte energy expenditure and thermogenesis. However, the source of IL-10 necessary for the suppression of adipocyte thermogenesis is unknown. We show here that CD4+Foxp3+ regulatory T cells (Tregs) are a substantial source of IL-10 and that Treg-derived IL-10 can suppress adipocyte beiging. Unexpectedly, Treg-specific loss of IL-10 resulted in increased insulin sensitivity and reduced obesity in high-fat diet-fed male mice. Mechanistically, we determined that Treg-specific loss of the transcription factor Blimp-1, a driver of IL-10 expression by Tregs, phenocopied the Treg-specific IL-10-deficient mice. Loss of Blimp-1 expression in Tregs resulted in reduced ST2+KLRG1+, IL-10-secreting Tregs, particularly in the white adipose tissue. Blimp-1-deficient mice were protected from glucose intolerance, insulin resistance, and diet-induced obesity, through increased white adipose tissue browning. Taken together, our data show that Blimp-1-regulated IL-10 secretion by Tregs represses white adipose tissue beiging to maintain adipose tissue homeostasis.

Indexed as

Adipose Tissue, BeigeAdipose Tissue, WhiteAnimalsDiet, High-FatGlucose IntoleranceInsulin ResistanceInterleukin-10MaleMiceMice, KnockoutMice, TransgenicObesityPositive Regulatory Domain I-Binding Factor 1ThermogenesisT-Lymphocytes, RegulatoryIL10 protein, mouseInterleukin-10Positive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseAdipose tissueCytokinesEndocrinologyImmunologyT cells

Identifiers

PMID33351782
PMCPMC7934851
OpenAlexW3113944511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.